SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-18-028502
Filing Date
2018-04-30
Accepted
2018-04-30 16:05:47
Documents
8
Period of Report
2018-05-23
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A a18-11271_1def14a.htm DEF 14A 823106
2 GRAPHIC g112711boi001.gif GRAPHIC 3792
3 GRAPHIC g112711bci001.jpg GRAPHIC 3722
4 GRAPHIC g112711bci002.jpg GRAPHIC 2440
5 GRAPHIC g112711bci003.jpg GRAPHIC 3717
6 GRAPHIC g112711bci004.jpg GRAPHIC 1930
7 GRAPHIC g112711cgi001.gif GRAPHIC 107225
8 GRAPHIC g112711cgi002.gif GRAPHIC 70774
  Complete submission text file 0001104659-18-028502.txt   1091725
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | Fiscal Year End: 0131
Type: DEF 14A | Act: 34 | File No.: 001-33818 | Film No.: 18789669
SIC: 3845 Electromedical & Electrotherapeutic Apparatus